Warning: Javascript must be enabled within your browser's settings for this site to function properly.

Your browser appears to be out of date, and is not supported by this site. For the best experience, we recommend that you upgrade to a more modern browser. You can find a list of modern browsers from www.browsehappy.com.

We use technical and analytics cookies data to ensure that we give you the best experience on our website. For more information visit our Privacy Page.

BWXT $   $  
As of . Minimum 20 minute delay.


BWXT Medical and NorthStar Medical Radioisotopes Sign Supply Agreement Supporting Actinium-225 Production

22 July 2024

BWXT Medical Ltd., a subsidiary of BWX Technologies, Inc. (NYSE: BWXT) and NorthStar Medical Radioisotopes, LLC (NorthStar) today announced that they have signed a Master Services Agreement (MSA), which will facilitate the production of actinium-225 (Ac-225), a critical medical isotope used to kill cancer cells while minimizing the impact to healthy tissues.

BWXT to Evaluate Locations for Building New Nuclear TRISO Fuel Production Facility to Support Advanced Reactor Deployment

18 July 2024

(LYNCHBURG, Va. – July 18, 2024) – BWX Technologies, Inc. (NYSE: BWXT) is evaluating locations for a potential new TRISO nuclear fuel production facility to support anticipated future demand for advanced reactor deployment. As part of this effort, BWXT’s Advanced Technologies subsidiary has signed a cooperation agreement with the State of Wyoming to evaluate the requirements for siting a fuel fabrication facility in the state. The roughly 18-month effort will evaluate such matters as potential factory locations, product specifications, facility design and engineering, estimated capital expenditures and operating costs, staffing and worker skill requirements, supply chain necessities, licensing and other requirements.

BWXT Awarded Phase Two of Microreactor Evaluation Contract for State of Wyoming

17 June 2024

(LYNCHBURG, Va. – June 17, 2024) – BWX Technologies, Inc. (NYSE: BWXT) today announced the award of the second phase of a contract with the Wyoming Energy Authority to assess the viability of deploying small-scale nuclear reactors in the state as a source of resilient and reliable energy to augment existing power generation resources.

BWXT-led Team Awarded $30 Billion Management and Operating Contract for National Nuclear Security Administration’s Pantex Plant

14 June 2024

(LYNCHBURG, Va. – June 14, 2024) – BWX Technologies, Inc. (NYSE: BWXT) today announced a contract award from the U.S. Department of Energy, National Nuclear Security Administration (DOE/NNSA) for management and operations of the Pantex Plant. Following an initial term of five years, NNSA has the ability to award three additional five-year option periods. If all contract options are exercised, the contract will span 20 years at a funding level of approximately $30 billion.

BWXT Medical Submits Drug Master File for Actinium-225 API to U.S. Food and Drug Administration

07 June 2024

BWXT Medical Ltd. has submitted a Drug Master File (DMF) to the U.S. Drug and Food Administration (FDA) for No Carrier Added (n.c.a.) Actinium-225 (Ac-225) Active Pharmaceutical Ingredient.

BWXT employees trained as Nuclear Ambassadors

28 May 2024
BWXT employees trained as Nuclear Ambassadors

BWX Technologies, Inc. (BWXT) has partnered with the American Nuclear Society to offer customized ANS Nuclear Ambassadors training to BWXT employees.

BWXT Names John Lucio as Senior Director for Government Relations

01 May 2024

BWX Technologies, Inc. has hired John Lucio as a senior director for government relations.

BWXT Named First Member of GE Vernova Nuclear’s Small Modular Reactor Supplier Group

29 April 2024

BWXT Canada Ltd., a subsidiary of BWX Technologies, Inc. has been selected as the first qualified supply chain company to join the GE Vernova nuclear business’ supplier group that will advance the global deployment of the BWRX-300 small modular reactor (SMR).

BWXT Announces Expansion of Cambridge Manufacturing Plant to Support Global Nuclear Power Market

19 April 2024

BWX Technologies, Inc. (NYSE: BWXT) announced an investment to expand its Cambridge manufacturing plant.

Press Contacts:

BWX Technologies, Inc.

Jud Simmons 
+1 434.522.3800

BWXT Canada Ltd.
BWXT Nuclear Energy Canada Inc.
BWXT Medical Ltd.

Monifa Miller
+1 519.242.8071

Nuclear Fuel Services, Inc.

Laura Bailey 
+1 423.743.9141